Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-25T08:45:49.063Z Has data issue: false hasContentIssue false
  • English
  • Français

A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial

Published online by Cambridge University Press:  05 March 2014

C. Barrowclough ,
M. Marshall ,
L. Gregg ,
M. Fitzsimmons ,
B. Tomenson ,
J. Warburton  and
F. Lobban
C. Barrowclough*
Affiliation:
Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK
M. Marshall
Affiliation:
Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK Lancashire Care NHS Foundation Trust, Preston, Lancashire, UK
L. Gregg
Affiliation:
Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK
M. Fitzsimmons
Affiliation:
Lancashire Care NHS Foundation Trust, Preston, Lancashire, UK School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK
B. Tomenson
Affiliation:
Institute of Population Health, University of Manchester, Manchester, UK
J. Warburton
Affiliation:
Lancashire Care NHS Foundation Trust, Preston, Lancashire, UK
F. Lobban
Affiliation:
Division of Health Research, Lancaster University, Lancaster, UK
*
*Address for correspondence: Professor C. Barrowclough, School of Psychological Sciences, University of Manchester, 2nd Floor Zochonis Building, Brunswick Street, Manchester M13 9PL, UK. (Email: christine.barrowclough@manchester.ac.uk)
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Cannabis use is high amongst young people who have recently had their first episode of psychosis, and is associated with worse outcomes. To date, interventions to reduce cannabis consumption have been largely ineffective, and it has been suggested that longer treatment periods are required.

Method

In a pragmatic single-blind randomized controlled trial 110 participants were randomly allocated to one of three conditions: a brief motivational interviewing and cognitive behavioural therapy (MI-CBT) intervention (up to 12 sessions over 4.5 months) with standard care from an early intervention service; a long MI-CBT intervention (up to 24 sessions over 9 months) with standard care; or standard care alone. The primary outcome was change in cannabis use as measured by Timeline Followback.

Results

Neither the extended nor the brief interventions conferred benefit over standard care in terms of reductions in frequency or amount of cannabis use. Also the interventions did not result in improvements in the assessed clinical outcomes, including symptoms, functioning, hospital admissions or relapse.

Conclusions

Integrated MI and CBT for people with cannabis use and recent-onset psychosis does not reduce cannabis use or improve clinical outcomes. These findings are consistent with those in the published literature, and additionally demonstrate that offering a more extended intervention does not confer any advantage. Many participants were not at an action stage for change and for those not ready to reduce or quit cannabis, targeting associated problems rather than the cannabis use per se may be the best current strategy for mental health services to adopt.

Keywords

Cannabispsychosisrecent onset
Type
Original Articles
Information
Psychological Medicine , Volume 44 , Issue 13 , October 2014 , pp. 2749 - 2761
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addington, D, Addington, J, Matickatyndale, E (1993). Assessing depression in schizophrenia – the Calgary Depression Scale. British Journal of Psychiatry 163, 39–44.Google Scholar
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, revised. American Psychological Association: Washington, DC.Google Scholar
Baker, AL, Hides, L, Lubman, DI (2010). Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review. Journal of Clinical Psychiatry 71, 247–254.Google Scholar
Barnett, JH, Werners, U, Secher, SM, Hill, KE, Brazil, R, Masson, K, Pernet, DE, Kirkbride, JB, Murray, GK, Bullmore, ET, Jones, PB (2007). Substance use in a population-based clinic sample of people with first-episode psychosis. British Journal of Psychiatry 190, 515–520.Google Scholar
Barrowclough, C, Emsley, R, Eisner, E, Beardmore, R, Wykes, T (2013). Does change in cannabis use in established psychosis affect clinical outcome? Schizophrenia Bulletin 39, 339–348.Google Scholar
Barrowclough, C, Haddock, G, Wykes, T, Beardmore, R, Conrod, P, Craig, T, Davies, L, Dunn, G, Eisner, E, Lewis, S, Moring, J, Steel, C, Tarrier, N (2010). Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. British Medical Journal 341, c6325.Google Scholar
Beck, AT, Brown, G, Epstein, N, Steer, RA (1988). An inventory for measuring clinical anxiety – psychometric properties. Journal of Consulting and Clinical Psychology 56, 893–897.Google Scholar
Birchwood, M, Lester, H, McCarthy, L, Jones, P, Fowler, D, Amos, T, Freemantle, N, Sharma, V, Lavis, A, Singh, S, Marshall, M (2013). The UK national evaluation of the development and impact of Early Intervention Services (the National EDEN studies): study rationale, design and baseline characteristics. Early Intervention in Psychiatry. Published online 24 01 2013 . doi:10.1111/eip.12007.Google Scholar
Birchwood, M, Todd, P, Jackson, C (1998). Early intervention in psychosis. The critical period hypothesis. British Journal of Psychiatry Supplement 172, 53–59.Google Scholar
Boden, MT, McKay, JR, Long, WR, Bonn-Miller, MO (2013). The effects of cannabis use expectancies on self-initiated cannabis cessation. Addiction 108, 1649–1657.Google ScholarPubMed
Bonsack, C, Gibellini Manetti, S, Favrod, J, Montagrin, Y, Besson, J, Bovet, P, Conus, P (2011). Motivational intervention to reduce cannabis use in young people with psychosis: a randomized controlled trial. Psychotherapy and Psychosomatics 80, 287–297.Google Scholar
Cantwell, R, Brewin, J, Glazebrook, C, Dalkin, T, Fox, R, Medley, I, Harrison, G (1999). Prevalence of substance misuse in first-episode psychosis. British Journal of Psychiatry 174, 150–153.Google Scholar
Cleghorn, JM, Kaplan, RD, Szechtman, B, Szechtman, H, Brown, GM, Franco, S (1991). Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. Journal of Clinical Psychiatry 52, 26–30.Google Scholar
Copeland, J, Swift, W (2009). Cannabis use disorder: epidemiology and management. International Review of Psychiatry 21, 96–103.CrossRefGoogle ScholarPubMed
Denis, C, Lavie, E, Auriacombe, M (2008). Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database Systematic Review, Issue 3. Art. No.: CD005336. DOI: 10.1002/14651858.CD005336.pub2.Google Scholar
Department of Health (2001). Mental Health Policy Implementation Guide. Department of Health: London.Google Scholar
Drake, RE, Mueser, KT, McHugo, GJ (1996). Clinician rating scales: Alcohol Use Scale (AUS), Drug Use Scale (DUS), and Substance Abuse Treatment Scale (SATS). In Outcomes Assessment in Clinical Practice (ed. Sederer, L. and Dickey, B.), pp. 113–116. Williams and Wilkins: Baltimore, MD.Google Scholar
Edwards, J, Elkins, K, Hinton, M, Harrigan, SM, Donovan, K, Athanasopoulos, O, McGorry, PD (2006). Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica 114, 109–117.Google Scholar
First, MB, Spitzer, RL, Gibbon, M, Williams, JB (1997). Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). American Psychiatric Press: Washington, DC.Google Scholar
Gates, P, Copeland, J, Swift, W, Martin, G (2012). Barriers and facilitators to cannabis treatment. Drug and Alcohol Review 31, 311–319.CrossRefGoogle ScholarPubMed
Gregg, L, Barrowclough, C, Haddock, G (2009 a). Development and validation of a scale for assessing reasons for substance use in schizophrenia: The ReSUS scale. Addictive Behaviors 34, 830–837.CrossRefGoogle ScholarPubMed
Gregg, L, Haddock, G, Barrowclough, C (2009 b). Self reported reasons for substance use in schizophrenia: a Q methodological investigation. Mental Health and Substance Use 2, 24–39.Google Scholar
Haddock, G, Beardmore, R, Earnshaw, P, Fitzsimmons, M, Nothard, S, Butler, R, Eisner, E, Barrowclough, C (2012). Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI-CBT fidelity scale (MI-CTS). Journal of Mental Health 21, 38–48.Google Scholar
Hjorthøj, CR, Fohlmann, A, Larsen, AM, Arendt, M, Nordentoft, M (2012 a). Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction 107, 1123–1131.Google Scholar
Hjorthøj, CR, Fohlmann, A, Larsen, AM, Gluud, C, Arendt, M, Nordentoft, M (2012 b). Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine 43, 1499–1510.CrossRefGoogle ScholarPubMed
Hogan, TP, Awad, AG (1992). Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychological Medicine 22, 347–352.Google Scholar
Hogan, TP, Awad, AG, Eastwood, R (1983). A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine 13, 177–183.Google Scholar
Kay, SR, Fiszbein, A, Opler, LA (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261–276.Google Scholar
Lambert, M, Conus, P, Lubman, DI, Wade, D, Yuen, H, Moritz, S, Naber, D, McGorry, PD, Schimmelmann, BG (2005). The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatrica Scandinavica 112, 141–148.Google Scholar
Linszen, DH, Dingemans, PM, Lenior, ME (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 51, 273–279.Google Scholar
Madigan, K, Brennan, D, Lawlor, E, Turner, N, Kinsella, A, O'Connor, JJ, Russell, V, Waddington, JL, O'Callaghan, E (2013). A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research 143, 138–142.Google Scholar
Moyers, TB, Martin, T, Manuel, JK, Hendrickson, SM, Miller, WR (2005). Assessing competence in the use of motivational interviewing. Journal of Substance Abuse Treatment 28, 19–26.Google Scholar
Rollnick, S, Heather, N, Gold, R, Hall, W (1992). Development of a short ‘readiness to change’ questionnaire for use in brief, opportunistic interventions among excessive drinkers. British Journal of Addiction 87, 743–754.Google Scholar
Schofield, D, Tennant, C, Nash, L, Degenhardt, L, Cornish, A, Hobbs, C, Brennan, G (2006). Reasons for cannabis use in psychosis. Australia and New Zealand Journal of Psychiatry 40, 570–574.Google Scholar
Schulz, KF, Altman, DG, Moher, D (2010). CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. British Medical Journal 340, c332.Google Scholar
Sembhi, S, Lee, JW (1999). Cannabis use in psychotic patients. Australia and New Zealand Journal of Psychiatry 33, 529–532.Google Scholar
Sobell, LC, Sobell, MB (1992). Timeline followback: a technique for assessing self-reported alcohol consumption. In Measuring Alcohol Consumption: Psychosocial and Biological Methods (ed. Litten, R. Z. and Allen, J.), pp. 41–72. Humana Press: Totowa, NJ.CrossRefGoogle Scholar
Sorbara, F, Liraud, F, Assens, F, Abalan, F, Verdoux, H (2003). Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. European Psychiatry 18, 133–136.Google Scholar
Tracey, TJ, Kokotovic, AM (1989). Factor structure of the Working Alliance Inventory. Psychological Assessment 1, 207–210.Google Scholar
Verdoux, H, Liraud, F, Gonzales, B, Assens, F, Abalan, F, van Os, J (2001). Predictors and outcome characteristics associated with suicidal behaviour in early psychosis: a two-year follow-up of first-admitted subjects. Acta Psychiatrica Scandinavica 103, 347–354.Google Scholar
Wade, D, Harrigan, S, Edwards, J, Burgess, PM, Whelan, G, McGorry, PD (2006). Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophrenia Research 81, 145–150.Google Scholar
Zammit, S, Moore, TH, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, Lewis, G (2008). Effects of cannabis use on outcomes of psychotic disorders: systematic review. British Journal of Psychiatry 193, 357–363.Google Scholar